Patents Assigned to Cresilon, Inc.
  • In-situ cross-linkable polymeric compositions and methods thereof
    Patent number: 11383005
    Abstract: A biocompatible polymeric composition for cross-linking in-situ in a wound is disclosed comprising 1) one or more polyanionic polymers such as alginates or hyaluronates, able to be cross-linked the surface of the wound and 2) one or more polycationic polymers such as chitosan or DEAE-Dextran, that assists in the solidification process as well as speeds up hemostasis without the need for applying pressure. The biocompatible polymeric composition may further comprise a cross-linking agent such as aqueous calcium chloride. The invention encompasses an initial polymeric composition, the solidified matrix cross-linked and integrated at the wound site, including the methods of using, applying, and cross-linking the composition.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: July 12, 2022
    Assignee: Cresilon, Inc.
    Inventor: Joseph A. Landolina
  • In-situ cross-linkable polymeric compositions and methods thereof
    Patent number: 10850003
    Abstract: A biocompatible polymeric composition for cross-linking in-situ in a wound is disclosed comprising 1) one or more polyanionic polymers such as alginates or hyaluronates, able to be cross-linked the surface of the wound and 2) one or more polycationic polymers such as chitosan or DEAE-Dextran, that assists in the solidification process as well as speeds up hemostasis without the need for applying pressure. The biocompatible polymeric composition may further comprise a cross-linking agent such as aqueous calcium chloride. The invention encompasses an initial polymeric composition, the solidified matrix cross-linked and integrated at the wound site, including the methods of using, applying, and cross-linking the composition.
    Type: Grant
    Filed: June 1, 2017
    Date of Patent: December 1, 2020
    Assignee: Cresilon, Inc.
    Inventor: Joseph A. Landolina
  • In-situ cross-linkable polymeric compositions and methods thereof
    Patent number: 9687584
    Abstract: A biocompatible polymeric composition for cross-linking in-situ in a wound is disclosed comprising 1) one or more polyanionic polymers such as alginates or hyaluronates, able to be cross-linked the surface of the wound and 2) one or more polycationic polymers such as chitosan or DEAE-Dextran, that assists in the solidification process as well as speeds up hemostasis without the need for applying pressure. The biocompatible polymeric composition may further comprise a cross-linking agent such as aqueous calcium chloride. The invention encompasses an initial polymeric composition, the solidified matrix cross-linked and integrated at the wound site, including the methods of using, applying, and cross-linking the composition.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: June 27, 2017
    Assignee: Cresilon, Inc.
    Inventor: Joseph A. Landolina
  • Delivery device for hemostatic compositions
    Patent number: D909570
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: February 2, 2021
    Assignee: CRESILON, INC.
    Inventors: Omar Ahmad, Jonathan Lee, Matthew Swift, Joseph Landolina